Patents by Inventor Chitose Orii

Chitose Orii has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7605226
    Abstract: The purpose of the present invention is to provide a novel protein involved in adhesion and fusion between myoblasts in the course of the formation of byotube. The present invention relates to Meltrins, which a membrane protein having fusion, adhesion and aggregation activity of cells, especially myoblast; and to polypeptides of their domains, DNAs encoding them, antisense RNA for these DNAs, various antibodies to Meltrins and the polypeptides of their domains, expression vectors containing these DNAs, and transformants by these vectors; as well as to the process for producing Meltrins and the polypeptides of their domains using those transformants and medical compositions comprising Meltrins or antagonist against them as an effective ingredient.
    Type: Grant
    Filed: March 13, 2006
    Date of Patent: October 20, 2009
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Atsuko Fujisawa, Toru Yamakawa, Kamon Shirakawa, Chitose Orii, Naoki Ogawa
  • Publication number: 20060247164
    Abstract: The purpose of the present invention is to provide a novel protein involved in adhesion and fusion between myoblasts in the course of the formation of byotube. The present invention relates to Meltrins, which a membrane protein having fusion, adhesion and aggregation activity of cells, especially myoblast; and to polypeptides of their domains, DNAs encoding them, antisense RNA for these DNAs, various antibodies to Meltrins and the polypeptides of their domains, expression vectors containing these DNAs, and transformants by these vectors; as well as to the process for producing Meltrins and the polypeptides of their domains using those transformants and medical compositions comprising Meltrins or antagonist against them as an effective ingredient.
    Type: Application
    Filed: March 13, 2006
    Publication date: November 2, 2006
    Applicant: MOCHIDA PHARMACEUTICAL CO., LTD.
    Inventors: Atsuko Fujisawa, Toru Yamakawa, Kamon Shirakawa, Chitose Orii, Naoki Ogawa
  • Patent number: 7060791
    Abstract: The purpose of the present invention is to provide a novel protein involved in adhesion and fusion between myoblasts in the course of the formation of byotube. The present invention relates to Meltrins, which a membrane protein having fusion, adhesion and aggregation activity of cells, especially myoblast; and to polypeptides of their domains, DNAs encoding them, antisense RNA for these DNAs, various antibodies to Meltrins and the polypeptides of their domains, expression vectors containing these DNAs, and transformants by these vectors; as well as to the process for producing Meltrins and the polypeptides of their domains using those transformants and medical compositions comprising Meltrins or antagonist against them as an effective ingredient.
    Type: Grant
    Filed: October 24, 2001
    Date of Patent: June 13, 2006
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Atsuko Fujisawa, Toru Yamakawa, Kamon Shirakawa, Chitose Orii, Naoki Ogawa
  • Publication number: 20020147132
    Abstract: The purpose of the present invention is to provide a novel protein involved in adhesion and fusion between myoblasts in the course of the formation of byotube. The present invention relates to Meltrins, which a membrane protein having fusion, adhesion and aggregation activity of cells, especially myoblast; and to polypeptides of their domains, DNAs encoding them, antisense RNA for these DNAs, various antibodies to Meltrins and the polypeptides of their domains, expression vectors containing these DNAs, and transformants by these vectors; as well as to the process for producing Meltrins and the polypeptides of their domains using those transformants and medical compositions comprising Meltrins or antagonist against them as an effective ingredient.
    Type: Application
    Filed: October 24, 2001
    Publication date: October 10, 2002
    Applicant: Mochida Pharmaceutical Co., Ltd.
    Inventors: Atsuko Fujisawa, Toru Yamakawa, Kamon Shirakawa, Chitose Orii, Naoki Ogawa
  • Patent number: D716442
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: October 28, 2014
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Shinichiro Magome, Rieko Yamada, Chitose Orii
  • Patent number: D717428
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: November 11, 2014
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Günther Sendatzki, Shinichiro Magome, Rieko Yamada, Chitose Orii
  • Patent number: D717940
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: November 18, 2014
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Shinichiro Magome, Rieko Yamada, Chitose Orii
  • Patent number: D719257
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: December 9, 2014
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Shinichiro Magome, Rieko Yamada, Chitose Orii
  • Patent number: D722158
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: February 3, 2015
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Shinichiro Magome, Rieko Yamada, Chitose Orii